Liveyon
Biotechnology Research • 
Irvine, California, United States • 11-20 Employees
Company overview
| Headquarters | 7700 Irvine Center Drive, Suite #800, Irvine, California 92618, US |
| Phone number | +18445483966 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Regenerative Medicine, Global Export, Marketing/Branding For Doctors, Umbilical Cord Stem Cells |
| Founded | 2016 |
| Employees | 11-20 |
| Socials |
Key Contacts at Liveyon
Rommel F. Aleman
Director Of It
Rommel Aleman
Director Of Information Technology
Liveyon Email Formats
Liveyon uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About Liveyon
Liveyon LLC is the exclusive worldwide distributor of a regenerative medicine product that is derived from umbilical cord blood manufactured by Liveyon Labs. This product contains cells, stem cells and growth factors which may serve as a therapy for various degenerative. Stem cells and cell based therapies have shown tremendous promise; yet controlled studies are still needed in order to confirm its efficacy. Professional judgment and expertise is needed in using these therapies for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies or any regenerative medicine product to consult the national health data bases to evaluate current information from clinical trials. The FDA websites on human tissue should also be consulted to get its current evaluation of any regenerative therapy. Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based or regenerative medicine products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.
Liveyon revenue & valuation
| Annual revenue | $20,000,000 |
| Revenue per employee | $1,177,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $64,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Liveyon has 6 employees across 2 departments.
Departments
Number of employees
Funding Data
Liveyon has never raised funding before.
Italy
United Kingdom
Frequently asked questions
4.8
40,000 users
